tiprankstipranks
Trending News
More News >

Robert Cascella Insider Profile

88 Followers
Robert Cascella, CEO & President, Director at Hologic, holds 588.77K shares in Neuronetics (Ticker: STIM), holds 88.53K shares in REPRO-MED Systems (Ticker: KRMD), holds 53.42K shares in Mirion Technologies (Ticker: MIR).
tipranks
Robert Cascella

Robert Cascella
Hologic (HOLX)
CEO & President, Director

Ranked #1,091 out of 104,104 Corporate Insiders

Profitable Transactions

71%
5 out of 7 Profitable Transactions

Average Return

+115.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$33M
89.50%
4.73%
4.71%
1.06%
0.00% Others
A breakdown of Robert Cascella's holdings

Insider Roles

Hologic
(HOLX)
CEO & President, Director
Mirion Technologies
(MIR)
Director
Neuronetics
(STIM)
Director
REPRO-MED Systems
(KRMD)
Director
+1 other positions
Roles that Robert Cascella holds in companies

Most Profitable Insider Trade

Stock:
Neuronetics
(STIM)
Rating:Informative Buy
Date:Sep 13, 2024 - Sep 13, 2025
Return:+327.40%
The most profitable trade made by Robert Cascella

Robert Cascella's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Hologic
Jul 02, 2013
CEO & President, Director
Uninformative Sell
391.00K
$29.67M
Neuronetics
Oct 22, 2025
Director
Uninformative Buy
$1.56M
Mirion Technologies
May 16, 2025
Director
Uninformative Buy
$1.57M
REPRO-MED Systems
Oct 02, 2025
Director
Uninformative Buy
15.00K
$350.58K
Celestica
Director
List of latest transactions for each holding click on a transaction to see Robert Cascella's performance on stock

Robert Cascella insider profile FAQ

What is the percentage of profitable transactions made by Robert Cascella?
The percentage of profitable transactions made by Robert Cascella is 71%.
    What is the average return per transaction made by Robert Cascella?
    The average return per transaction made by Robert Cascella is 115.10%.
      What stocks does Robert Cascella hold?
      Robert Cascella holds: HOLX, STIM, MIR, KRMD, CLS stocks.
        What was Robert Cascella’s latest transaction?
        Robert Cascella latest transaction was an Uninformative Buy of ―.
          What was Robert Cascella's most profitable transaction?
          Robert Cascella’s most profitable transaction was an Informative Buy of STIM stock on September 13, 2024. The return on the trade was 327.40%.
            What is Robert Cascella's role in Hologic?
            Robert Cascella's role in Hologic is CEO & President, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.